The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
sildenafil  	sildenafil  	 JJ	B-NP
citrate  	citrate  	 JJ	I-NP
administration  	administration  	 NN	I-NP
on  	on  	 IN	O
selected  	selected  	 JJ	O
physiological  	physiological  	 JJ	B-NP
parameters  	parameters  	 NNS	I-NP
of  	of  	 IN	O
exercising  	exercising  	 VBG	O
Thoroughbred  	Thoroughbred  	 JJ	O
horses  	horses  	 NNS	O
Sildenafil 	Sildenafil 	 NNP	B-NP
,  	,  	 ,	O
a  	a  	 DT	O
phosphodiesterase-5  	phosphodiesterase-5  	 FW	B-NP
inhibitor  	inhibitor  	 FW	I-NP
vasodilator 	vasodilator 	 FW	I-NP
,  	,  	 ,	O
increases  	increases  	 VBZ	O
cGMP  	cGMP  	 JJ	B-NP
concentrations  	concentrations  	 NNS	I-NP
by  	by  	 IN	O
inhibiting  	inhibiting  	 JJ	O
enzymatic  	enzymatic  	 JJ	B-NP
degradation 	degradation 	 NN	I-NP
.  	.  	 .	O
Marketed  	Marketed  	 VBN	O
to  	to  	 TO	O
treat  	treat  	 VB	O
erectile  	erectile  	 JJ	O
dysfunction  	dysfunction  	 NN	B-NP
in  	in  	 IN	O
men 	men 	 NNS	O
,  	,  	 ,	O
it  	it  	 PRP	O
also  	also  	 RB	O
reduces  	reduces  	 VBZ	O
pulmonary  	pulmonary  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
pressure  	pressure  	 NN	I-NP
( 	( 	 -LRB-	O
PAP 	PAP 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
Because  	Because  	 IN	O
it  	it  	 PRP	O
reduces  	reduces  	 VBZ	O
PAP 	PAP 	 NNP	O
,  	,  	 ,	O
sildenafil  	sildenafil  	 NNS	B-NP
may  	may  	 MD	O
enhance  	enhance  	 VB	O
performance  	performance  	 NN	O
and 	and 	 CC	O
/ 	/ 	 NNP	O
or  	or  	 CC	O
prevent  	prevent  	 VB	O
exercise  	exercise  	 VB	B-NP
induced-pulmonary  	induced-pulmonary  	 JJ	I-NP
haemorrhage  	haemorrhage  	 NNS	I-NP
( 	( 	 -LRB-	O
EIPH 	EIPH 	 NNP	B-NP
) 	) 	 -RRB-	O
.  	.  	 .	O
To  	To  	 TO	O
determine  	determine  	 VB	O
if  	if  	 IN	O
sildenafil  	sildenafil  	 JJ	B-NP
citrate  	citrate  	 JJ	I-NP
administration  	administration  	 NN	I-NP
altered  	altered  	 VBD	O
commonly  	commonly  	 RB	O
measured  	measured  	 VBN	B-NP
indices  	indices  	 NNS	I-NP
of  	of  	 IN	O
performance  	performance  	 NN	O
or  	or  	 CC	O
reduced  	reduced  	 VBD	B-NP
EIPH  	EIPH  	 NNP	I-NP
in  	in  	 IN	O
exercised  	exercised  	 JJ	O
horses 	horses 	 NNS	O
.  	.  	 .	O
Thirteen  	Thirteen  	 FW	O
athletically  	athletically  	 FW	O
conditioned  	conditioned  	 FW	O
Thoroughbred  	Thoroughbred  	 FW	O
horses  	horses  	 FW	O
( 	( 	 -LRB-	O
2  	2  	 CD	O
mares  	mares  	 NNS	O
and  	and  	 CC	O
11  	11  	 CD	O
geldings 	geldings 	 NN	O
,  	,  	 ,	O
age  	age  	 NN	O
3-12  	3-12  	 CD	O
years 	years 	 NNS	O
)  	)  	 -RRB-	O
were  	were  	 VBD	O
administered  	administered  	 VBN	O
sildenafil  	sildenafil  	 JJ	B-NP
citrate  	citrate  	 NN	I-NP
or  	or  	 CC	O
placebo  	placebo  	 NN	O
in  	in  	 IN	O
2  	2  	 CD	O
crossover  	crossover  	 JJ	O
design  	design  	 NN	O
exercise  	exercise  	 NN	B-NP
testing  	testing  	 NN	I-NP
studies 	studies 	 NNS	I-NP
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
step-wise  	step-wise  	 JJ	B-NP
test  	test  	 NN	I-NP
to  	to  	 TO	O
exhaustion 	exhaustion 	 VB	O
,  	,  	 ,	O
inspired 	inspired 	 VBD	B-NP
/ 	/ 	 NNP	I-NP
expired  	expired  	 VBD	I-NP
gas  	gas  	 NN	I-NP
analysis 	analysis 	 NN	I-NP
,  	,  	 ,	O
blood  	blood  	 NN	B-NP
lactate 	lactate 	 NN	I-NP
,  	,  	 ,	O
heart  	heart  	 NN	B-NP
rate 	rate 	 NN	I-NP
,  	,  	 ,	O
runtime  	runtime  	 NN	B-NP
and  	and  	 CC	O
bronchoalveolar  	bronchoalveolar  	 JJ	B-NP
lavage  	lavage  	 NNS	I-NP
( 	( 	 -LRB-	O
BAL 	BAL 	 NNP	B-NP
)  	)  	 -RRB-	O
cytology  	cytology  	 NN	B-NP
were  	were  	 VBD	O
measured 	measured 	 VBN	O
.  	.  	 .	O
In  	In  	 IN	O
a  	a  	 DT	O
13  	13  	 CD	O
m 	m 	 CD	B-NP
/ 	/ 	 CD	I-NP
s  	s  	 JJ	I-NP
test  	test  	 NN	I-NP
to  	to  	 TO	O
exhaustion 	exhaustion 	 VB	O
,  	,  	 ,	O
blood  	blood  	 NN	B-NP
lactate 	lactate 	 NN	I-NP
,  	,  	 ,	O
heart  	heart  	 NN	B-NP
rate 	rate 	 NN	I-NP
,  	,  	 ,	O
runtime 	runtime 	 NN	B-NP
,  	,  	 ,	O
BAL  	BAL  	 NNP	B-NP
cytology  	cytology  	 NN	I-NP
and  	and  	 CC	O
pulmonary  	pulmonary  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
pressure  	pressure  	 NN	I-NP
were  	were  	 VBD	O
measured 	measured 	 VBN	O
.  	.  	 .	O
Data  	Data  	 NNP	O
were  	were  	 VBD	O
analysed  	analysed  	 VBN	O
with  	with  	 IN	O
paired  	paired  	 NN	O
and  	and  	 CC	O
unpaired  	unpaired  	 JJ	B-NP
t  	t  	 JJ	I-NP
tests 	tests 	 NNS	I-NP
,  	,  	 ,	O
one-way  	one-way  	 JJ	B-NP
ANOVA  	ANOVA  	 NNP	I-NP
and  	and  	 CC	O
Tukey 	Tukey 	 NNP	O
's  	's  	 POS	O
pair-wise  	pair-wise  	 JJ	B-NP
multiple  	multiple  	 JJ	O
comparison  	comparison  	 NN	O
and  	and  	 CC	O
Friedman  	Friedman  	 NNP	O
repeated  	repeated  	 VBD	B-NP
measure  	measure  	 NN	I-NP
analysis  	analysis  	 NN	I-NP
of  	of  	 IN	O
variance  	variance  	 NN	O
on  	on  	 IN	O
ranks 	ranks 	 NNS	O
.  	.  	 .	O
The  	The  	 DT	O
administration  	administration  	 NN	B-NP
of  	of  	 IN	I-NP
sildenafil  	sildenafil  	 NN	I-NP
did  	did  	 VBD	O
not  	not  	 RB	O
alter  	alter  	 VB	O
mean  	mean  	 VB	O
inspired 	inspired 	 VBN	B-NP
/ 	/ 	 NNP	I-NP
expired  	expired  	 VBD	I-NP
gas  	gas  	 NN	I-NP
measurements 	measurements 	 NNS	I-NP
,  	,  	 ,	O
plasma  	plasma  	 JJ	B-NP
lactate  	lactate  	 JJ	I-NP
concentrations  	concentrations  	 NNS	I-NP
or  	or  	 CC	O
acute  	acute  	 JJ	O
pulmonary  	pulmonary  	 JJ	B-NP
haemorrhage  	haemorrhage  	 NN	I-NP
in  	in  	 IN	O
either  	either  	 DT	O
exercise  	exercise  	 NN	B-NP
test  	test  	 NN	I-NP
or  	or  	 CC	O
pulmonary  	pulmonary  	 JJ	B-NP
arterial  	arterial  	 JJ	I-NP
pressure  	pressure  	 NN	I-NP
measurement  	measurement  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
13  	13  	 CD	O
m 	m 	 CD	B-NP
/ 	/ 	 CD	I-NP
s  	s  	 JJ	I-NP
trial 	trial 	 NN	I-NP
.  	.  	 .	O
Heart  	Heart  	 NN	B-NP
rates  	rates  	 NNS	I-NP
in  	in  	 IN	O
both  	both  	 DT	O
stress  	stress  	 NN	B-NP
tests  	tests  	 NNS	I-NP
were  	were  	 VBD	O
significantly  	significantly  	 RB	O
different  	different  	 JJ	O
at  	at  	 IN	O
submaximal  	submaximal  	 JJ	B-NP
speeds  	speeds  	 NNS	I-NP
and  	and  	 CC	O
during  	during  	 IN	O
the  	the  	 DT	O
early  	early  	 JJ	O
recovery  	recovery  	 NN	B-NP
period 	period 	 NN	I-NP
.  	.  	 .	O
Run  	Run  	 NN	B-NP
time  	time  	 NN	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
affected  	affected  	 VBN	O
by  	by  	 IN	O
sildenafil  	sildenafil  	 JJ	B-NP
administration  	administration  	 NN	I-NP
in  	in  	 IN	O
the  	the  	 DT	O
step-wise  	step-wise  	 JJ	B-NP
trial  	trial  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.622 	0.622 	 CD	O
)  	)  	 -RRB-	O
or  	or  	 CC	O
in  	in  	 IN	O
the  	the  	 DT	O
13  	13  	 CD	O
m 	m 	 CD	B-NP
/ 	/ 	 CD	I-NP
s  	s  	 JJ	I-NP
trial  	trial  	 NN	I-NP
( 	( 	 -LRB-	O
P  	P  	 NN	O
=  	=  	 SYM	O
0.059 	0.059 	 CD	O
) 	) 	 -RRB-	O
.  	.  	 .	O
Sildenafil  	Sildenafil  	 NNP	B-NP
did  	did  	 VBD	O
not  	not  	 RB	O
alleviate  	alleviate  	 VB	O
pulmonary  	pulmonary  	 JJ	B-NP
haemorrhage  	haemorrhage  	 NN	I-NP
or  	or  	 CC	O
enhance  	enhance  	 VB	O
performance-related  	performance-related  	 JJ	O
indices  	indices  	 NNS	O
in  	in  	 IN	O
these  	these  	 DT	O
trials 	trials 	 NNS	O
.  	.  	 .	O
Sildenafil  	Sildenafil  	 JJ	B-NP
administration  	administration  	 NN	I-NP
altered  	altered  	 VBD	O
cardiovascular  	cardiovascular  	 JJ	B-NP
adaptation  	adaptation  	 NN	I-NP
to  	to  	 TO	O
intense  	intense  	 JJ	O
exercise  	exercise  	 NN	O
as  	as  	 IN	O
evidenced  	evidenced  	 VBN	O
by  	by  	 IN	O
altered  	altered  	 JJ	O
heart  	heart  	 NN	B-NP
rates  	rates  	 NNS	I-NP
at  	at  	 IN	O
submaximal  	submaximal  	 JJ	B-NP
speeds  	speeds  	 NNS	I-NP
and  	and  	 CC	O
post  	post  	 NN	O
exercise 	exercise 	 NN	O
.  	.  	 .	O
The  	The  	 DT	O
effect  	effect  	 NN	O
of  	of  	 IN	O
these  	these  	 DT	O
alterations  	alterations  	 NN	O
on  	on  	 IN	O
other  	other  	 JJ	O
performance  	performance  	 NN	B-NP
perimeters  	perimeters  	 NNS	I-NP
was  	was  	 VBD	O
not  	not  	 RB	O
evident 	evident 	 JJ	O
.  	.  	 .	O
